NCT07272499 2025-12-09Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk DiseaseRuijin HospitalPhase 2 Recruiting25 enrolled
NCT04496349 2025-11-04A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHLAscentage Pharma Group Inc.Phase 2 Recruiting78 enrolled